Could ERG Preferences For Different Overall Survival Extrapolation Methodologies Drive Different Nice Appraisal Outcomes?

October 18, 2018 Danielle Twigg

Since 2011, Adrian Bagust and Nicholas Latimer, from Liverpool Reviews and Implementation Group (LRiG) and the Sheffield School of Health and Related Research (ScHARR) respectively, have debated the competing strengths of alternative approaches to modelling survival data. Since Evidence Review Groups (ERGs) are responsible for the critical appraisal of companies’ submissions to the National Institute of Health and Care Excellence (NICE), this research aims to identify if different ERGs have different extrapolation approach preferences.

Authors: Berardi A, Dave K, Macaulay R, Guest S

To find out more about this poster you can register to download it here after the ISPOR event.

Previous Article
Danish Medicine Council Process Of Assessing New Hospital Medicines – First Year Of Implementation
Danish Medicine Council Process Of Assessing New Hospital Medicines – First Year Of Implementation

Next Article
A Review Of Recent Appraisals From The Institute For Clinical And Economic Review: How Important Is The ICER?
A Review Of Recent Appraisals From The Institute For Clinical And Economic Review: How Important Is The ICER?